Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Guy

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|January 9, 2014
Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathyJohn Guy, William J Feuer, Vittorio Porciatti, et al.
JAMA Ophthalmology|February 15, 2014
Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trialByron L Lam, William J Feuer, Joyce C Schiffman, et al.
American Journal of Ophthalmology|March 10, 2022
Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient GroupsByron L Lam, William J Feuer, Janet L Davis, et al.
International Journal of Molecular Sciences|December 9, 2023
Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber's Hereditary Optic NeuropathyTsung-Han Chou, Zixuan Hao, Diego Alba, et al.
Annals of Neurology|October 29, 2002
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic NeuropathyJohn Guy, Xiaoping Qi, Francesco Pallotti, et al.
Current Eye Research|May 23, 2020
Non-invasive Assessment of Central Retinal Artery Pressure: Age and Posture-dependent ChangesMaja Kostic, Phillip Gordon, Pedro Monsalve, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MSVenu Talla, Hong Yu, Tsung-Han Chou, et al.
Investigative Ophthalmology & Visual Science|April 24, 2009
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual systemJohn Guy, Xiaoping Qi, Rajeshwari D Koilkonda, et al.
Diabetes Care|December 19, 2008
Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control studyJohn Guy, Lorraine Ogden, R Paul Wadwa, et al.
Molecular Vision|December 24, 2008
Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)John Guy, Gerry Shaw, Fred N Ross-Cisneros, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|January 9, 2014
Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathyJohn Guy, William J Feuer, Vittorio Porciatti, et al.
JAMA Ophthalmology|February 15, 2014
Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trialByron L Lam, William J Feuer, Joyce C Schiffman, et al.
American Journal of Ophthalmology|March 10, 2022
Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient GroupsByron L Lam, William J Feuer, Janet L Davis, et al.
International Journal of Molecular Sciences|December 9, 2023
Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber's Hereditary Optic NeuropathyTsung-Han Chou, Zixuan Hao, Diego Alba, et al.
Annals of Neurology|October 29, 2002
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic NeuropathyJohn Guy, Xiaoping Qi, Francesco Pallotti, et al.
Current Eye Research|May 23, 2020
Non-invasive Assessment of Central Retinal Artery Pressure: Age and Posture-dependent ChangesMaja Kostic, Phillip Gordon, Pedro Monsalve, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MSVenu Talla, Hong Yu, Tsung-Han Chou, et al.
Investigative Ophthalmology & Visual Science|April 24, 2009
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual systemJohn Guy, Xiaoping Qi, Rajeshwari D Koilkonda, et al.
Diabetes Care|December 19, 2008
Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control studyJohn Guy, Lorraine Ogden, R Paul Wadwa, et al.
Molecular Vision|December 24, 2008
Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)John Guy, Gerry Shaw, Fred N Ross-Cisneros, et al.
Pageof 7